Shepelkova G, Evstifeev V, Berezovskiy Y, Ergeshova A, Tarasov R, Bagirov M
Int J Mol Sci. 2024; 25(21).
PMID: 39519346
PMC: 11546853.
DOI: 10.3390/ijms252111795.
Klepp L, Blanco F, Bigi M, Vazquez C, Garcia E, Sabio Y Garcia J
Antibodies (Basel). 2024; 13(4).
PMID: 39449326
PMC: 11503302.
DOI: 10.3390/antib13040084.
Gern B, Klas J, Foster K, Cohen S, Plumlee C, Duffy F
bioRxiv. 2024; .
PMID: 38659794
PMC: 11042216.
DOI: 10.1101/2024.04.12.589315.
Kumari R, Kumar R, Anita , Muni S, Kumar S, Kumari N
Cureus. 2024; 16(3):e55688.
PMID: 38595894
PMC: 11002332.
DOI: 10.7759/cureus.55688.
Helle O, Kanthali M, Ishtiaq S, Ambreen A, Purohit M, Mustafa T
J Pathol Clin Res. 2024; 10(3):e12373.
PMID: 38572528
PMC: 10993049.
DOI: 10.1002/2056-4538.12373.
Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated .
Montero-Vega M, Matilla J, Bazan E, Reimers D, De Andres-Martin A, Gonzalo-Gobernado R
Cells. 2024; 13(6.
PMID: 38534380
PMC: 10969755.
DOI: 10.3390/cells13060536.
A spotlight on the tuberculosis epidemic in South Africa.
Nat Commun. 2024; 15(1):1290.
PMID: 38346962
PMC: 10861440.
DOI: 10.1038/s41467-024-45491-w.
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis.
Weeratunga P, Moller D, Ho L
J Clin Invest. 2024; 134(1).
PMID: 38165044
PMC: 10760966.
DOI: 10.1172/JCI175264.
High and Low Levels of Expression Are Associated with Two Distinct Gene Signatures in Lung Tissue of Pulmonary TB Patients with High Inflammation Activity.
Pavlova E, Lepekha L, Rybalkina E, Tarasov R, Sychevskaya K, Voronezhskaya E
Int J Mol Sci. 2023; 24(19).
PMID: 37834286
PMC: 10573207.
DOI: 10.3390/ijms241914839.
A half-century of research on tuberculosis: Successes and challenges.
Bloom B
J Exp Med. 2023; 220(9).
PMID: 37552470
PMC: 10407785.
DOI: 10.1084/jem.20230859.
in a Trap: The Role of Neutrophil Extracellular Traps in Tuberculosis.
Cavalcante-Silva L, Almeida F, de Andrade A, Comberlang F, Cardoso L, Vanderley S
Int J Mol Sci. 2023; 24(14).
PMID: 37511144
PMC: 10379580.
DOI: 10.3390/ijms241411385.
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management.
Chopra H, Mohanta Y, Ranjan Rauta P, Ahmed R, Mahanta S, Mishra P
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111338
PMC: 10145450.
DOI: 10.3390/ph16040581.
Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi.
Gordon S, Sichone S, Chirwa A, Hazenberg P, Kafuko Z, Ferreira D
Wellcome Open Res. 2023; 8:71.
PMID: 37007907
PMC: 10064019.
DOI: 10.12688/wellcomeopenres.18767.2.
Improved diagnosis of extrapulmonary tuberculosis in adults with and without HIV in Mbeya, Tanzania using the MPT64 antigen detection test.
Gronningen E, Nanyaro M, Sviland L, Ngadaya E, Muller W, Torres L
PLOS Glob Public Health. 2023; 2(11):e0001317.
PMID: 36962852
PMC: 10021170.
DOI: 10.1371/journal.pgph.0001317.
Mouse Models for Pathogenesis: Show and Do Not Tell.
Soldevilla P, Vilaplana C, Cardona P
Pathogens. 2023; 12(1).
PMID: 36678397
PMC: 9865329.
DOI: 10.3390/pathogens12010049.
Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates.
Ulain N, Ali A, Khan M, Ullah Z, Shaheen L, Shareef N
PLoS One. 2022; 17(10):e0276064.
PMID: 36228032
PMC: 9560136.
DOI: 10.1371/journal.pone.0276064.
The paradox of immune checkpoint inhibition re-activating tuberculosis.
Ahmed M, Tezera L, Elkington P, Leslie A
Eur Respir J. 2022; 60(5).
PMID: 35595321
PMC: 9647068.
DOI: 10.1183/13993003.02512-2021.
Anti-tuberculosis treatment strategies and drug development: challenges and priorities.
Dartois V, Rubin E
Nat Rev Microbiol. 2022; 20(11):685-701.
PMID: 35478222
PMC: 9045034.
DOI: 10.1038/s41579-022-00731-y.
and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.
Meca A, Mititelu-Tartau L, Bogdan M, Dijmarescu L, Pelin A, Foia L
J Pers Med. 2022; 12(4).
PMID: 35455684
PMC: 9027178.
DOI: 10.3390/jpm12040569.
Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies.
Brown R, Hunter R
Pathogens. 2021; 10(12).
PMID: 34959527
PMC: 8708170.
DOI: 10.3390/pathogens10121572.